Alexion rises after AstraZeneca gets U.S. nod for takeover deal Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Alexion Pharmaceuticals (ALXN) up 4% after announcing AstraZeneca's (AZN) proposed acquisition of the company has cleared FTC review
- Dicerna (DRNA) up 3% after Goldman Sachs analyst Madhu Kumar initiated coverage of shares with a Buy rating and $48 price target, implying 73% upside potential
- Esports Technologies (EBET) up 31% after opening at $21 per share yesterday after its IPO priced at $6 per share
UP AFTER EARNINGS -
- Ally Financial (ALLY) up 1%
- State Street (STT) up 1%
- PPG (PPG) up 5%
- Morgan Stanley (MS) up 1%
DOWN AFTER EARNINGS -
- BNY Mellon (BK) down 2%
- Citizens Financial (CFG) down 1%
LOWER -
- Editas Medicine (EDIT) down 7% after Goldman Sachs analyst Madhu Kumar initiated coverage of the stock with a Sell rating and $20 price target, implying 52% downside potential
Symbols:
STT ALXN DRNA EBET - $36.05 /
+12.95 (+56.06%)
CFG ALLY PPG MS BK EDIT AZN Keywords: Fly Intel, Wall Street, Top Stories, Stocks